查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1873994

切片设备市场

Biopsy Devices Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格
简介目录

预计活检设备市场将从 2024 年的 30 亿美元增长到 2031 年的 45.9 亿美元，2031 年至 2031 年的年复合成长率(CAGR) 为 6.20%。推动活检设备市场成长的关键趋势包括癌症发病率上升、活检手术增加以及活检技术的进步。

切片设备市场分析

市场成长的驱动因素包括：人们对微创手术的偏好日益增长、癌症诊断率的激增以及政府旨在提高癌症检测率的倡议。活检是多种癌症（包括乳腺癌、皮肤癌和前列腺癌）的关键诊断方法。泛美卫生组织的数据显示，未来20年全球癌症负担预计将增加约60%，到2040年预计将新增3,000万例癌症病例，尤其是中低收入国家。因此，癌症发生率的上升和活检技术的进步预计将在预测期内推动市场成长。

切片设备市场概览

北美地区在活检器械市场占据领先地位，其中美国市场份额最大，其次是加拿大。对微创活检手术的需求显着推动了北美市场的成长。根据美国整形外科医师协会统计，2022年美国共进行了约23,672,269例美容性微创手术，这带动了对活检器械的需求，进而促进了市场成长。

战略洞察

活检设备市场驱动因素与机会

癌症发生率上升推高了对活检设备的需求

全球癌症病例的激增是推动活检设备市场发展的主要因素。准确及时的癌症诊断对于有效治疗至关重要，因此活检成为一种重要的诊断工具。世界卫生组织报告称，2022年全球新增癌症病例约2,000万例，癌症相关死亡病例约970万例，五分之一的人一生中可能会罹患癌症。因此，活检设备对于识别恶性组织和辅助医生製定治疗方案至关重要。

活体组织检查设备的科技创新带来市场机会

医疗技术的进步和快速创新是市场成长的重要推动因素。多年来，这些发展显着提高了活检手术的有效性、速度和安全性。例如，真空辅助活检设备能够更快、更舒适地提取组织样本。此外，将CT扫描、超音波或MRI等即时影像技术与活检设备结合，可实现更精准的标靶定位，减少併发症，并提高诊断准确性。这些技术进步正在推动医疗专业人员对活检设备的接受度不断提高，从而进一步促进了活检设备市场的发展。

活检设备市场报告細項分析

活检设备市场分析按产品、技术和应用进行细分。

  • 该产品类别包括针刺活检、定位导丝、手术托盘和其他产品，其中针刺活检设备因其高精度和最小的损伤，在 2023 年占据了最大的市场份额。
  • 从技术角度来看，市场分为 CT 扫描、超音波引导活检、立体定位引导活检、MRI 引导活检和其他，其中超音波引导活检在 2023 年占据最大份额，而 CT 扫描在预测期内复合年增长率最高。
  • 从应用领域来看，市场分为肺活检、肾臟活检、肝臟活检、乳房活检和其他，其中乳房活检领域在 2023 年占据了市场份额的领先地位。

按地域分類的活检设备市场份额分析

活检设备市场报告涵盖五个主要地区：北美、亚太地区、欧洲、中东和非洲以及南美/中南美洲。

北美在活检设备市场占据主导地位，这主要得益于活检设备在各种应用领域的日益普及、癌症病例数量的不断增长、主要製造商的存在，以及製药和生物技术公司在北美医疗器材领域的投资。根据泛美卫生组织统计，癌症是美洲第二大疾病和死亡原因，仅次于心血管疾病。 2020年，美洲新增癌症病例约400万例，癌症死亡病例约140万例。不断增长的癌症确诊患者群体将增加对活检设备的需求，从而推动市场成长。

活检设备市场报告范围

活检设备市场最新发展

活检器械市场评估是基于从一手和二手研究中获得的定性和定量资料，包括重要的企业出版物、协会资料和资料库。活检器械市场的最新发展包括：

  • TransMed7公司宣布，其商业化生产版Heron XPS设备已完成首次人体临床试验。该设备是新型真空辅助单次插入/多次采集软组织活检设备系列中的一款。 （资料来源：Transmed7，新闻稿/公司网站/简报，2022年8月）
  • 波士顿科学公司（Boston Scientific Corporation）的WATCHMAN FLX Pro左心耳封堵器获得FDA批准，该装置旨在提高非瓣膜性房颤患者（需要口服抗凝血治疗替代方案）的手术操作性和安全性。 （资料来源：波士顿科学公司，新闻稿/公司网站/简报，2023年9月）
  • 丹纳赫公司旗下子公司Mammotome推出了Mammotome Revolve™ EX双真空辅助乳房切片系统，这是首款专为切除良性乳房病变而设计的设备，提供了一种微创解决方案，可最大限度地降低风险和疤痕。 （资料来源：丹纳赫公司，新闻稿/公司网站/简报，2022年8月）

活检设备市场报告涵盖范围和成果

《活检设备市场规模及预测（2021-2031）》报告对市场进行了全面分析，涵盖以下领域：

  • 全球、区域和国家层面所有主要细分市场的市场规模和预测。
  • 市场动态，包括驱动因素、限制因素和主要机会。
  • 未来趋势分析。
  • 详细的PEST/波特五力模型和SWOT分析。
  • 全球及区域市场分析，涵盖关键趋势、主要参与者、法规及最新发展。
  • 产业格局和竞争分析，包括市场集中度、热力图分析、主要参与者和最新发展。
  • 深入的公司概况。

目录

第一章：引言

第二章：切片设备市场及主要结论

第三章：研究方法

  • 覆盖范围
  • 二手研究
  • 初步研究

第四章：切片设备市场概况

  • 概述
  • PEST分析
    • 北美和PEST分析
    • 欧洲和PEST分析
    • 亚太地区及PEST分析
    • 中东和非洲以及 PEST 分析
    • 南美洲和中美洲以及 PEST 分析
  • 专家意见
  • 报销方案

第五章：全球切片设备市场及产业动态

  • 市场驱动因素
    • 癌症发生率不断上升
    • 政府支持和倡议
  • 市场限制
    • 活检的局限性
  • 市场机会
    • 提高大众对疾病早期检测的认识
  • 未来趋势
    • 产品设计持续改进
  • 驾驶员和约束装置的影响分析

第六章：切片设备市场及全球分析

  • 全球切片设备市场概览
  • 全球切片设备市场及收入预测与分析
  • 全球切片设备市场（依地域划分）－预测与分析
  • 关键参与者的市场定位

第七章：切片设备市场分析及产品分类

  • 概述
  • 活检设备市场（按产品划分），2024 年和 2031 年（%）
  • 针刺切片
  • 定位线
  • 手术托盘
  • 其他的

第八章：切片设备市场分析及技术分类

  • 概述
  • 按技术分類的活检设备市场，2024 年和 2031 年（%）
  • CT扫描
  • 超音波引导下切片
  • 立体定位引导活检
  • 磁振造影引导切片
  • 其他的

第九章：切片设备市场分析及应用

  • 概述
  • 活检设备市场，按应用领域划分，2024 年和 2031 年（市场份额百分比）
  • 肺活检
  • 肾臟活检
  • 肝臟切片
  • 乳腺活检
  • 其他的

第十章：切片设备市场及地理分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 瑞典
    • 丹麦
    • 挪威
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿联酋
    • 南非
  • 南美洲和中美洲
    • 巴西
    • 阿根廷

第十一章：新冠肺炎疫情对全球切片设备市场的影响

  • 北美洲
  • 欧洲
  • 亚太
  • 世界其他地区

第十二章：切片设备市场及产业概况

  • 概述
  • 市场中各公司采取的成长策略（%）
  • 有机发展
    • 概述
  • 无机物发展
    • 概述

第十三章：公司简介

  • BD
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Cardinal Health Inc.
  • Cook Medical LLC
  • Danaher
  • Fujifilm Corporation
  • Hologic, Inc.
  • Medtronic
  • Argon Medical Devices

第十四章：附录

简介目录
Product Code: TIPHE100001402

The Biopsy Devices Market is anticipated to grow from US$ 3.00 billion in 2024 to US$ 4.59 billion by 2031, reflecting a compound annual growth rate (CAGR) of 6.20% during the period from 2031 to 2031. Key trends driving the Biopsy Devices market include the rising incidence of cancer, an increase in biopsy procedures, and advancements in biopsy technology.

Biopsy Devices Market Analysis

The market growth is being propelled by factors such as a growing preference for minimally invasive procedures, a surge in cancer diagnoses, and government initiatives aimed at improving cancer detection. Biopsy is a crucial diagnostic method for various cancers, including breast, skin, and prostate cancers. Data from the Pan American Health Organization indicates that the global cancer burden is expected to rise by about 60% over the next 20 years, with an estimated 30 million new cancer cases projected by 2040, particularly in low- and middle-income nations. Consequently, the increasing cancer incidence and advancements in biopsy technology are expected to drive market growth during the forecast period.

Biopsy Devices Market Overview

North America leads the Biopsy Devices market, with the United States holding the largest share, followed by Canada. The demand for minimally invasive biopsy procedures significantly contributes to the growth of the North American market. According to the American Society of Plastic Surgeons, approximately 23,672,269 cosmetic minimally invasive procedures were performed in the U.S. in 2022, which drives the need for biopsy devices and subsequently boosts market growth.

Strategic Insights

Biopsy Devices Market Drivers and Opportunities

Increasing Cancer Prevalence Boosts Demand for Biopsy Devices

The global rise in cancer cases is a major factor driving the biopsy device market. Accurate and early cancer diagnosis is essential for effective treatment, making biopsy a vital diagnostic tool. The World Health Organization reported approximately 20 million new cancer cases and 9.7 million cancer-related deaths in 2022, with 1 in 5 individuals likely to develop cancer in their lifetime. Thus, biopsy devices are crucial for identifying malignant tissues and assisting physicians in formulating treatment plans.

Technological Innovations in Biopsy Devices Present Market Opportunities

Advancements in medical technology and rapid innovations are significant contributors to market growth. These developments have enhanced the efficacy, speed, and safety of biopsy procedures over the years. For example, vacuum-assisted biopsy devices facilitate quicker and more comfortable tissue sample extraction. Moreover, integrating real-time imaging techniques such as CT scans, ultrasounds, or MRIs with biopsy devices allows for more precise targeting, fewer complications, and improved diagnostic accuracy. Such technological progress is leading to increased adoption rates among healthcare professionals, further driving the biopsy device market.

Biopsy Devices Market Report Segmentation Analysis

The Biopsy Devices Market analysis is segmented by product, technology, and application.

  • The product segment includes Needle-Based Biopsy, Localization Wires, Procedure Trays, and Others, with needle-based biopsy devices capturing the largest market share in 2023 due to their high accuracy and minimal injury.
  • In terms of technology, the market is divided into CT Scan, Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, MRI-Guided Biopsy, and Others, where the Ultrasound-Guided Biopsy segment held the largest share in 2023, while the CT Scan segment exhibited the fastest CAGR during the forecast period.
  • For applications, the market is categorized into Lung Biopsy, Kidney Biopsy, Liver Biopsy, Breast Biopsy, and Others, with the Breast Biopsy segment leading the market share in 2023.

Biopsy Devices Market Share Analysis by Geography

The Biopsy Devices Market report covers five main regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.

North America dominates the Biopsy Devices Market, driven by the increasing adoption of biopsy devices across various applications, a rising number of cancer cases, the presence of major manufacturers, and investments from pharmaceutical and biotech companies in medical devices within North America. According to the Pan American Health Organization, cancer is the second leading cause of morbidity and mortality in the Americas, following cardiovascular diseases, with an estimated 4 million new cancer diagnoses and 1.4 million cancer deaths in 2020. This growing diagnosed cancer population will increase the demand for biopsy devices, thereby fueling market growth.

Biopsy Devices Market Report Scope

Recent Developments in the Biopsy Devices Market

The Biopsy Devices Market is assessed through qualitative and quantitative data obtained from primary and secondary research, including significant corporate publications, association data, and databases. Recent developments in the Biopsy Devices market include:

  • TransMed7, LLC announced a "First in Human" clinical case for the commercial production version of the Heron XPS device, part of a new family of vacuum-assisted, single insertion/multiple collection soft tissue biopsy devices. (Source: Transmed7, Press Release/Company Website/Newsletter, August 2022)
  • Boston Scientific Corporation received FDA approval for the WATCHMAN FLX Pro Left Atrial Appendage Closure Device, designed to enhance procedural performance and safety for patients with non-valvular atrial fibrillation needing alternatives to oral anticoagulation therapy. (Source: Boston Scientific Corporation, Press Release/Company Website/Newsletter, September 2023)
  • Mammotome, a subsidiary of Danaher Corporation, launched the Mammotome RevolveTM EX Dual Vacuum-Assisted Breast Biopsy System, the first device specifically designed for the excision of benign breast lesions, offering a minimally invasive solution that minimizes risks and scarring. (Source: Danaher Corporation, Press Release/Company Website/Newsletter, August 2022)

Biopsy Devices Market Report Coverage and Deliverables

The "Biopsy Devices Market Size and Forecast (2021-2031)" report provides a comprehensive analysis of the market, covering the following areas:

  • Market size and forecast at global, regional, and country levels for all key market segments.
  • Market dynamics including drivers, restraints, and key opportunities.
  • Future trends analysis.
  • Detailed PEST/Porter's Five Forces and SWOT analysis.
  • Global and regional market analysis covering key trends, major players, regulations, and recent developments.
  • Industry landscape and competition analysis, including market concentration, heat map analysis, prominent players, and recent developments.
  • In-depth company profiles.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Biopsy Devices Market and By Product
    • 1.3.2 Biopsy Devices Market and By Technology
    • 1.3.3 Biopsy Devices Market and By Application
    • 1.3.4 Biopsy Devices Market and By Geography

2. Biopsy Devices Market and Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Biopsy Devices Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America and PEST Analysis
    • 4.2.2 Europe and PEST Analysis
    • 4.2.3 Asia-Pacific and PEST Analysis
    • 4.2.4 Middle East and Africa and PEST Analysis
    • 4.2.5 South and Central America and PEST Analysis
  • 4.3 Expert Opinions
  • 4.4 Reimbursement Scenario

5. Global Biopsy Devices Market and Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Cancer Rates
    • 5.1.2 Government Support and Initiatives
  • 5.2 Market Restraints
    • 5.2.1 Limitations Associated with Biopsy
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Awareness Regarding Early Disease Detection
  • 5.4 Future Trends
    • 5.4.1 Consistent Improvement in Product Designs
  • 5.5 Impact Analysis of Drivers and Restraints

6. Biopsy Devices Market and Global Analysis

  • 6.1 Global Biopsy Devices Market - Overview
  • 6.2 Global Biopsy Devices Market and Revenue Forecasts and Analysis
  • 6.3 Global Biopsy Devices Market, By Geography - Forecast And Analysis
  • 6.4 Market Positioning of Key Players

7. Biopsy Devices Market Analysisand by Product

  • 7.1 Overview
  • 7.2 Biopsy Devices Market, By Product, 2024 and 2031 (%)
    • 7.2.1 Biopsy Devices Market Revenue and Forecasts to 2031, By Product (US$ Million)
    • 7.2.2 Needle-Based Biopsy Market Revenue and Forecasts to 2031, By Type (US$ Million)
  • 7.3 Needle-Based Biopsy
    • 7.3.1 Overview
    • 7.3.2 Needle-Based Biopsy Market Revenue and Forecasts to 2031 (US$ Million)
    • 7.3.3 Core Biopsy Devices
      • 7.3.3.1 Overview
      • 7.3.3.2 Core Biopsy Devices Market Revenue and Forecasts to 2031 (US$ Million)
    • 7.3.4 Aspiration Biopsy Needles
      • 7.3.4.1 Overview
      • 7.3.4.2 Aspiration Biopsy Needles Market Revenue and Forecasts to 2031 (US$ Million)
    • 7.3.5 Vacuum Assisted Biopsy (VAB) Devices
      • 7.3.5.1 Overview
      • 7.3.5.2 Vacuum Assisted Biopsy (VAB) Devices Market Revenue and Forecasts to 2031 (US$ Million)
  • 7.4 Localization Wires
    • 7.4.1 Overview
    • 7.4.2 Localization Wires Market Revenue and Forecasts to 2031 (US$ Million)
  • 7.5 Procedure Trays
    • 7.5.1 Overview
    • 7.5.2 Procedure Trays Market Revenue and Forecasts to 2031 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others Market Revenue and Forecasts to 2031 (US$ Million)

8. Biopsy Devices Market Analysisand by Technology

  • 8.1 Overview
  • 8.2 Biopsy Devices Market, By Technology, 2024 and 2031 (%)
    • 8.2.1 Biopsy Devices Market Revenue and Forecasts to 2031, By Technology (US$ Million)
  • 8.3 CT Scan
    • 8.3.1 Overview
    • 8.3.2 CT Scan Market Revenue and Forecasts to 2031 (US$ Million)
  • 8.4 Ultrasound Guided Biopsy
    • 8.4.1 Overview
    • 8.4.2 Ultrasound Guided Biopsy Market Revenue and Forecasts to 2031 (US$ Million)
  • 8.5 Stereotactic Guided Biopsy
    • 8.5.1 Overview
    • 8.5.2 Stereotactic Guided Biopsy Market Revenue and Forecasts to 2031 (US$ Million)
  • 8.6 MRI Guided Biopsy
    • 8.6.1 Overview
    • 8.6.2 MRI Guided Biopsy Market Revenue and Forecasts to 2031 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others Market Revenue and Forecasts to 2031 (US$ Million)

9. Biopsy Devices Market Analysisand by Application

  • 9.1 Overview
  • 9.2 Biopsy Devices Market, By Application, 2024 and 2031 (% Share)
    • 9.2.1 Biopsy Devices Market Revenue and Forecasts to 2031, By Application (US$ Million)
  • 9.3 Lung Biopsy
    • 9.3.1 Overview
    • 9.3.2 Lung Biopsy Market Revenue and Forecasts to 2031 (US$ Million)
  • 9.4 Kidney Biopsy
    • 9.4.1 Overview
    • 9.4.2 Kidney Biopsy Market Revenue and Forecasts to 2031 (US$ Million)
  • 9.5 Liver Biopsy
    • 9.5.1 Overview
    • 9.5.2 Liver Biopsy Market Revenue and Forecasts to 2031 (US$ Million)
  • 9.6 Breast Biopsy
    • 9.6.1 Overview
    • 9.6.2 Breast Biopsy Market Revenue and Forecasts to 2031 (US$ Million)
  • 9.7 Others
    • 9.7.1 Overview
    • 9.7.2 Others Market Revenue and Forecasts to 2031 (US$ Million)

10. Biopsy Devices Market and Geographic Analysis

  • 10.1 North America: Biopsy devices Market
    • 10.1.1 Overview
    • 10.1.2 North America: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
    • 10.1.3 North America: Biopsy devices Market, by Product, 2024 and 2031 (USD Million)
      • 10.1.3.1 North America: Needle-Based Biopsy Devices, Market, by Type, 2024 and 2031 (USD Million)
    • 10.1.4 North America: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
    • 10.1.5 North America: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
    • 10.1.6 North America: Biopsy devices Market, by Country, 2024 and 2031 (%)
    • 10.1.7 US: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
      • 10.1.7.1 US: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
      • 10.1.7.2 US: Biopsy devices Market, by Product, 2024 and 2031 (USD Million)
        • 10.1.7.2.1 US: Needle-Based Biopsy Devices, Market, by Type, 2024 and 2031 (USD Million)
      • 10.1.7.3 US: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
      • 10.1.7.4 US: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
    • 10.1.8 Canada: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
      • 10.1.8.1 Canada: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
      • 10.1.8.2 Canada: Biopsy devices Market, by Product, 2024 and 2031 (USD Million)
        • 10.1.8.2.1 Canada: Needle-Based Biopsy Devices, Market, by Type, 2024 and 2031 (USD Million)
      • 10.1.8.3 Canada: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
      • 10.1.8.4 Canada: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
    • 10.1.9 Mexico: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
      • 10.1.9.1 Mexico: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
      • 10.1.9.2 Mexico: Biopsy devices Market, by Product, 2024 and 2031 (USD Million)
        • 10.1.9.2.1 Mexico: Needle-Based Biopsy Devices, Market, by Type, 2024 and 2031 (USD Million)
      • 10.1.9.3 Mexico: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
      • 10.1.9.4 Mexico: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
  • 10.2 Europe: Biopsy devices Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Biopsy devices Market - Revenue and Forecast to 2031 (USD Million)
    • 10.2.3 Europe: Biopsy devices Market, by Product, 2024 and 2031 (USD Million)
      • 10.2.3.1 Europe: Needle-Based Biopsy Devices, Market, by Type, 2024 and 2031 (USD Million)
    • 10.2.4 Europe: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
    • 10.2.5 Europe: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
    • 10.2.6 Europe: Biopsy devices Market, by Country, 2024 and 2031 (%)
    • 10.2.7 Germany: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.7.1 Germany: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.7.2 Germany: Biopsy devices Market, by Product, 2024 and 2031 (USD Million)
        • 10.2.7.2.1 Germany: Needle-Based Biopsy Devices, Market, by Type, 2024 and 2031 (USD Million)
      • 10.2.7.3 Germany: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
      • 10.2.7.4 Germany: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
    • 10.2.8 UK: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.8.1 UK: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.8.2 UK: Biopsy devices Market, by Product, 2024 and 2031 (USD Million)
        • 10.2.8.2.1 UK: Needle-Based Biopsy Devices, Market, by Type, 2024 and 2031 (USD Million)
      • 10.2.8.3 UK: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
      • 10.2.8.4 UK: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
    • 10.2.9 France: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.9.1 France: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.9.2 France: Biopsy devices Market, by Product, 2024 and 2031 (USD Million)
        • 10.2.9.2.1 France: Needle-Based Biopsy Devices, Market, by Type, 2024 and 2031 (USD Million)
      • 10.2.9.3 France: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
      • 10.2.9.4 France: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
    • 10.2.10 Spain: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.10.1 Spain: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.10.2 Spain: Biopsy devices Market, by Product, 2024 and 2031 (USD Million)
        • 10.2.10.2.1 Spain: Needle-Based Biopsy Devices, Market, by Type, 2024 and 2031 (USD Million)
      • 10.2.10.3 Spain: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
      • 10.2.10.4 Spain: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
    • 10.2.11 Italy: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.11.1 Italy: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.11.2 Italy: Biopsy devices Market, by Product, 2024 and 2031 (USD Million)
        • 10.2.11.2.1 Italy: Needle-Based Biopsy Devices, Market, by Type, 2024 and 2031 (USD Million)
      • 10.2.11.3 Italy: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
      • 10.2.11.4 Italy: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
    • 10.2.12 Sweden: Biopsy Devices Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.12.1 Sweden: Biopsy Devices Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.12.2 Sweden: Biopsy Devices Market, by Product, 2024 and 2031 (USD Million)
        • 10.2.12.2.1 Sweden: Needle-Based Biopsy Devices, Market, by Type, 2024 and 2031 (USD Million)
      • 10.2.12.3 Sweden: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
      • 10.2.12.4 Sweden: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
    • 10.2.13 Denmark: Biopsy Devices Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.13.1 Denmark: Biopsy Devices Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.13.2 Denmark: Biopsy Devices Market, by Product, 2024 and 2031 (USD Million)
        • 10.2.13.2.1 Denmark: Needle-Based Biopsy Devices, Market, by Type, 2024 and 2031 (USD Million)
      • 10.2.13.3 Denmark: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
      • 10.2.13.4 Denmark: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
    • 10.2.14 Norway: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.14.1 Norway: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.14.2 Norway: Biopsy devices Market, by Product, 2024 and 2031 (USD Million)
        • 10.2.14.2.1 Norway: Needle-Based Biopsy Devices, Market, by Type, 2024 and 2031 (USD Million)
      • 10.2.14.3 Norway: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
      • 10.2.14.4 Norway: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
  • 10.3 Asia-Pacific: Biopsy Devices Market
    • 10.3.1 Overview
    • 10.3.2 Asia-Pacific: Biopsy Devices Market and Revenue and Forecast to 2031 (USD Millions)
    • 10.3.6 Asia-Pacific: Biopsy Devices Market, by Country, 2024 and 2031 (%)
    • 10.3.7 China: Biopsy Devices Market
      • 10.3.7.1 China: Biopsy Devices Market and Revenue and Forecast to 2031 (USD Millions)
      • 10.3.7.2 China: Biopsy Devices Market, by Product, 2024 and 2031 (USD Million)
        • 10.3.7.2.1 China: Needle-Based Biopsy Devices Market, by Type, 2024 and 2031 (USD Million)
      • 10.3.7.3 China: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
      • 10.3.7.4 China: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
    • 10.3.8 Japan: Biopsy Devices Market
      • 10.3.8.1 Japan: Biopsy Devices Market and Revenue and Forecast to 2031 (USD Millions)
      • 10.3.8.2 Japan: Biopsy Devices Market, by Product, 2024 and 2031 (USD Million)
        • 10.3.8.2.1 Japan: Needle-Based Biopsy Devices Market, by Type, 2024 and 2031 (USD Million)
      • 10.3.8.3 Japan: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
      • 10.3.8.4 Japan: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
    • 10.3.9 India: Biopsy Devices Market
      • 10.3.9.1 India: Biopsy Devices Market and Revenue and Forecast to 2031 (USD Millions)
      • 10.3.9.2 India: Biopsy Devices Market, by Product, 2024 and 2031 (USD Million)
        • 10.3.9.2.1 India: Needle-Based Biopsy Devices Market, by Type, 2024 and 2031 (USD Million)
      • 10.3.9.3 India: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
      • 10.3.9.4 India: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
    • 10.3.10 South Korea: Biopsy Devices Market
      • 10.3.10.1 South Korea: Biopsy Devices Market and Revenue and Forecast to 2031 (USD Millions)
      • 10.3.10.2 South Korea: Biopsy Devices Market, by Product, 2024 and 2031 (USD Million)
        • 10.3.10.2.1 South Korea: Needle-Based Biopsy Devices Market, by Type, 2024 and 2031 (USD Million)
      • 10.3.10.3 South Korea: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
      • 10.3.10.4 South Korea: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
    • 10.3.11 Australia: Biopsy Devices Market
      • 10.3.11.1 Australia: Biopsy Devices Market and Revenue and Forecast to 2031 (USD Millions)
      • 10.3.11.2 Australia: Biopsy Devices Market, by Product, 2024 and 2031 (USD Million)
        • 10.3.11.2.1 Australia: Needle-Based Biopsy Devices Market, by Type, 2024 and 2031 (USD Million)
      • 10.3.11.3 Australia: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
      • 10.3.11.4 Australia: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
  • 10.4 Middle East and Africa: Biopsy Devices Market
    • 10.4.1 Overview
    • 10.4.2 Middle East and Africa: Biopsy Devices Market- Revenue and Forecast to 2031 (USD Million)
    • 10.4.6 Middle East and Africa: Biopsy Devices Market, by Country, 2024 and 2031 (%)
    • 10.4.7 Saudi Arabia: Biopsy Devices Marketand Revenue and Forecast to 2031 (USD Million)
      • 10.4.7.1 Saudi Arabia: Biopsy Devices Marketand Revenue and Forecast to 2031 (USD Million)
      • 10.4.7.2 Saudi Arabia: Biopsy Devices Market, by Product, 2024 and 2031 (USD Million)
        • 10.4.7.2.1 Saudi Arabia: Needle-Based Biopsy Devices Market, by Type, 2024 and 2031 (USD Million)
      • 10.4.7.3 Saudi Arabia: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
      • 10.4.7.4 Saudi Arabia: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
    • 10.4.8 UAE: Biopsy Devices Marketand Revenue and Forecast to 2031 (USD Million)
      • 10.4.8.1 UAE: Biopsy Devices Marketand Revenue and Forecast to 2031 (USD Million)
      • 10.4.8.2 UAE: Biopsy Devices Market, by Product, 2024 and 2031 (USD Million)
        • 10.4.8.2.1 UAE: Needle-Based Biopsy Devices Market, by Type, 2024 and 2031 (USD Million)
      • 10.4.8.3 UAE: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
      • 10.4.8.4 UAE: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
    • 10.4.9 South Africa: Biopsy Devices Marketand Revenue and Forecast to 2031 (USD Million)
      • 10.4.9.1 South Africa: Biopsy Devices Marketand Revenue and Forecast to 2031 (USD Million)
      • 10.4.9.2 South Africa: Biopsy Devices Market, by Product, 2024 and 2031 (USD Million)
        • 10.4.9.2.1 South Africa: Needle-Based Biopsy Devices Market, by Type, 2024 and 2031 (USD Million)
      • 10.4.9.3 South Africa: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
      • 10.4.9.4 South Africa: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
  • 10.5 South and Central America: Biopsy devices Market
    • 10.5.1 Overview
    • 10.5.2 South and Central America: Biopsy devices Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.5.3 South and Central America: Biopsy devices Market, by Product, 2024 and 2031 (USD Million)
      • 10.5.3.1 South and Central America: Needle-Based Biopsy Devices, Market, by Type, 2024 and 2031 (USD Million)
    • 10.5.4 South and Central America: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
    • 10.5.5 South and Central America: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
    • 10.5.6 South and Central America: Biopsy devices Market, by Country, 2024 and 2031 (%)
    • 10.5.7 Brazil: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
      • 10.5.7.1 Brazil: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
      • 10.5.7.2 Brazil: Biopsy devices Market, by Product, 2024 and 2031 (USD Million)
        • 10.5.7.2.1 Brazil: Needle-Based Biopsy Devices, Market, by Type, 2024 and 2031 (USD Million)
      • 10.5.7.3 Brazil: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
      • 10.5.7.4 Brazil: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
    • 10.5.8 Argentina: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
      • 10.5.8.1 Argentina: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
      • 10.5.8.2 Argentina: Biopsy devices Market, by Product, 2024 and 2031 (USD Million)
        • 10.5.8.2.1 Argentina: Needle-Based Biopsy Devices, Market, by Type, 2024 and 2031 (USD Million)
      • 10.5.8.3 Argentina: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
      • 10.5.8.4 Argentina: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)

11. Impact of COVID-19 Pandemic on Global Biopsy Devices Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment Of COVID-19 Pandemic
  • 11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

12. Biopsy Devices Market and Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies Done by the Companies in the Market, (%)
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 BD
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 B. Braun Melsungen AG
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Boston Scientific Corporation
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Cardinal Health Inc.
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Cook Medical LLC
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Danaher
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Fujifilm Corporation
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Hologic, Inc.
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Medtronic
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Argon Medical Devices
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms